Published in JAMA on March 10, 1993
Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med (2008) 2.74
Colorectal cancer screening with odour material by canine scent detection. Gut (2011) 2.23
Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology (2011) 1.86
Screening for colorectal cancer. Scoop, 'scope, or skip? Can Fam Physician (1993) 1.62
Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry. World J Gastroenterol (2006) 1.60
Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations. Ann Surg Oncol (2011) 1.50
Screening for colorectal cancer. BMJ (1994) 1.28
The cost-effectiveness of CT colonography in screening for colorectal neoplasia. Am J Gastroenterol (2006) 1.23
Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen. Nat Commun (2014) 1.21
Correlates of colorectal cancer screening compliance among urban Hispanics. J Behav Med (2005) 1.04
Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries. BMC Cancer (2006) 1.04
Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination. CMAJ (1994) 0.96
Computed tomography colonography (virtual colonoscopy): a new method for colorectal screening. Gut (1999) 0.93
Iron homeostasis and distal colorectal adenoma risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Prev Res (Phila) (2011) 0.90
Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia. Dig Dis Sci (1997) 0.89
Colorectal cancer screening. World J Gastroenterol (2006) 0.88
How should we screen for colorectal cancer? JAMA (1993) 0.86
Colorectal cancer screening: you can't be positive about a negative result. CMAJ (2001) 0.84
Three-dimensional MR and axial CT colonography versus conventional colonoscopy for detection of colon pathologies. World J Gastroenterol (2006) 0.83
Virtual magnetic resonance colonography. Gut (2003) 0.83
Diagnostic value of a guaiac occult blood test and faecal alpha 1-antitrypsin. Gut (1995) 0.79
Screening for colon cancer. Cancer Imaging (2006) 0.79
Screening for colorectal cancer: the accuracy of fecal occult blood. JAMA (1993) 0.78
The impact of health insurance on an African-American population with colorectal cancer. J Natl Med Assoc (1995) 0.78
Quantitative profiling of CpG island methylation in human stool for colorectal cancer detection. Int J Colorectal Dis (2012) 0.78
Detection of Colorectal Cancer by Serum and Tissue Protein Profiling: A Prospective Study in a Population at Risk. Biomark Insights (2008) 0.77
Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening tests. World J Gastrointest Oncol (2016) 0.77
Immunodiscrimination of colorectal neoplasia using MUC1 antibodies: discrepant findings in tissue versus stool. Dig Dis Sci (2000) 0.77
Performance characteristics and comparison of two fecal occult blood tests in patients undergoing colonoscopy. Dig Dis Sci (2007) 0.77
What is the role of iFOBT in screening for colorectal cancer? Gut (2007) 0.77
Demographic differences in African-American patients with neoplastic lesions detected by flexible sigmoidoscopy. J Natl Med Assoc (1995) 0.75
Abdominal pain, diarrhea, constipation--which symptom is more indispensable to have a colonoscopy? Int J Clin Exp Pathol (2015) 0.75
The promise of methylation on beads for cancer detection and treatment. Expert Rev Mol Diagn (2014) 0.75
Screening for colorectal cancer: the accuracy of fecal occult blood. JAMA (1993) 0.75
Surveillance and Survivorship after Treatment for Colon Cancer. Clin Colon Rectal Surg (2015) 0.75
Colorectal cancer. JAMA (1993) 0.75
Advances in the screening and staging of colon and rectal cancers. West J Med (1993) 0.75
Detection rate of immunochemical fecal occult blood test for colorectal adenomatous polyps with severe dysplasia. J Gastroenterol (1997) 0.75
Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc (1980) 8.36
Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med (1991) 7.21
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med (1980) 6.12
Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst (1999) 5.92
Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet (2000) 4.43
The physician's responsibility toward hopelessly ill patients. A second look. N Engl J Med (1989) 4.20
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol (1989) 4.03
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med (1995) 3.83
Ultralong single-wall carbon nanotubes. Nat Mater (2004) 3.83
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst (1999) 3.46
Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol (1989) 3.44
High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med (1985) 3.36
Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res (1998) 3.36
Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med (1994) 3.29
Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst (2000) 3.27
Carcinoid tumors of the vermiform appendix. Cancer (1968) 3.07
Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol (1997) 3.04
It is now the age to define the appropriate follow-up of primary breast cancer patients. J Clin Oncol (1994) 3.00
Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer (1991) 2.98
Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med (1998) 2.95
Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet (1969) 2.94
Methodologic lessons learned from hot flash studies. J Clin Oncol (2001) 2.82
Phytochelatin synthase genes from Arabidopsis and the yeast Schizosaccharomyces pombe. Plant Cell (1999) 2.74
Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma. N Engl J Med (1980) 2.72
Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med (1986) 2.70
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med (1979) 2.63
Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol (2001) 2.54
Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology (1978) 2.52
Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol (1998) 2.51
Incidence of high blood lead levels in Chicago children. Pediatrics (1969) 2.46
The physician's responsibility toward hopelessly ill patients. N Engl J Med (1984) 2.46
Treatment of the carcinoid tumor and the malignant carcinoid syndrome. J Clin Oncol (1983) 2.41
Lovastatin therapy for cholesterol ester storage disease in two sisters. J Pediatr (1991) 2.41
Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial. Ann Intern Med (1991) 2.37
Surgical management of multiple polyposis. The problem of cancer in the retained bowel segment. Arch Surg (1970) 2.31
Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study. J Clin Oncol (1985) 2.26
Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. N Engl J Med (1997) 2.25
Incremental costs of enrolling cancer patients in clinical trials: a population-based study. J Natl Cancer Inst (1999) 2.25
Survival after postoperative combination treatment of rectal cancer. N Engl J Med (1986) 2.24
Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol (1998) 2.24
Prospective comparison of indirect methods for detecting lactase deficiency. N Engl J Med (1975) 2.18
Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet (1992) 2.15
Multiple primary malignant neoplasms: historical perspectives. Cancer (1977) 2.11
Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. J Clin Oncol (2000) 2.11
Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer. N Engl J Med (2001) 2.09
Brain metastases from colorectal carcinoma. The long term survivors. Cancer (1996) 2.01
The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc (1980) 2.01
Rad18 is required for DNA repair and checkpoint responses in fission yeast. Mol Biol Cell (1999) 1.98
Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol (1991) 1.93
Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. J Clin Oncol (1994) 1.93
Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst (1990) 1.92
Controlled clinical studies of orally administered antiemetic drugs. Gastroenterology (1969) 1.92
Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res (1989) 1.86
Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules. N Engl J Med (1977) 1.84
Fatty acids of Mycobacterium kansasii. Appl Microbiol (1971) 1.83
The effect of measuring error on the results of therapeutic trials in advanced cancer. Cancer (1976) 1.81
Mesenteric lipodystrophy. Ann Intern Med (1974) 1.80
Treatment of the patient with adenocarcinoma of unknown origin. Cancer (1972) 1.79
Wound recurrence following conventional treatment of colorectal cancer. A rare but perhaps underestimated problem. Dis Colon Rectum (1996) 1.77
Role for yeast inhibitor of apoptosis (IAP)-like proteins in cell division. Proc Natl Acad Sci U S A (1999) 1.77
Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology (1983) 1.76
Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract. Cancer Res (1975) 1.75
Clinical management of advanced gastrointestinal cancer. Cancer (1975) 1.74
Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol (1990) 1.74
Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. J Clin Oncol (1994) 1.67
Malignant lymphoma of bone. Cancer (1986) 1.66
An industrial outbreak of toxic hepatitis due to methylenedianiline. N Engl J Med (1974) 1.65
Rectal cancer following colectomy for polyposis. Arch Surg (1980) 1.63
Chemotherapy-induced peripheral neuropathy: prevention and treatment. Clin Pharmacol Ther (2011) 1.62
Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology (1996) 1.62
The G(2) DNA damage checkpoint targets both Wee1 and Cdc25. J Cell Sci (2000) 1.61
A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer. J Natl Cancer Inst (1996) 1.58
A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Breast and Bowel Project Protocol R-03. Dis Colon Rectum (1997) 1.58
Designs for group sequential phase II clinical trials. Biometrics (1987) 1.57
Chemotherapy of gastrointestinal cancer. N Engl J Med (1978) 1.56